MAPT and early-onset autosomal dominant Alzheimer disease: The inhibitory role ofw-Tau peptide not only for tau protein assembly but also for the inhibitionof amyloid β peptide polymerization may suggest a potentialuse as a tool to prevent tauopathies that are mainly characterizedby the presence of aberrant tau protein aggregates.16,17 The inhibition of amyloid aggregation could be also of interestfor the most relevant tauopathy, Alzheimer’s disease.